MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/09612033251414739

Медицинская библиотека · Lupus · 2026

Interleukin-23 levels and their association with systemic lupus erythematosus: A systematic review and meta-analysis.

Ranjan Shovit, Dubey Madhavi, Panda Aditya K

СтатьяСистематический обзорМетаанализПеревод в очереди

Аннотация

BackgroundSystemic Lupus Erythematosus (SLE) is a multisystemic autoimmune disease involving Interleukin-23 (IL-23), a pro-inflammatory cytokine that promotes Th17 cell differentiation, contributing to SLE pathogenesis. However, studies assessing IL-23 levels in SLE patients have reported inconsistent findings. This meta-analysis aimed to evaluate the association of circulating IL-23 levels with SLE, including their correlation with disease activity.Materials and MethodsFive databases (PubMed, Scopus, ScienceDirect, Web of Science, and EBSCOhost) were utilized for a systematic search of observational studies comparing IL-23 levels in SLE patients and healthy controls, along with the SLE Disease Activity Index (SLEDAI), to assess disease activity. The Newcastle-Ottawa Scale (NOS) was used for the data extraction process and quality assessment. Comprehensive Meta-Analysis (CMA) v4 was used as another tool to perform the meta-analysis. Moreover, robustness of findings was assured by Trial Sequential Analysis (TSA), sensitivity analysis, heterogeneity, and publication bias.ResultsResults were derived from 12 studies involving 680 SLE patients and 416 healthy controls. Elevated levels of IL-23 were reported in SLE patients compared to controls (MD = 71.467; 95% CI: 26.44-116.49; p = 0.002) in the pooled analysis. IL-23 levels were higher in active versus inactive SLE (MD = 27.777; p = 0.085), although the difference was statistically insignificant. A significant positive correlation was recorded between IL-23 and SLEDAI scores (correlation coefficient = 0.510; p = 0.027). Ethnicity-specific analysis supported similar trends in East Asian and Middle Eastern populations. Sensitivity and TSA confirmed the robustness and adequacy of the sample size for the association between IL-23 and SLE.ConclusionThis meta-analysis reveals a significant association between elevated IL-23 levels and SLE, suggesting its potential as a diagnostic and prognostic biomarker. Further longitudinal studies are required to validate its utility in SLE monitoring and therapy.

Для цитирования: Ranjan Shovit, Dubey Madhavi, Panda Aditya K. Interleukin-23 levels and their association with systemic lupus erythematosus: A systematic review and meta-analysis.. Lupus. 2026. DOI: 10.1177/09612033251414739.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.